Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Proteomika

2002 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
Description

Provider of biomarkers designed for non-invasive diagnosis of complex diseases. The company's biomarkers are diagnostic assays that offers individualized optimization of treatment regimes by measuring drug response, such as drug bioavailability and immunogenicity.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Primary Office
  • Parque Tecnológico de Bizkaia 504
  • 48160 Derio
  • Spain

+34 944 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Proteomika’s full profile, request a free trial.

Proteomika Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Jan-2015 Completed Generating Revenue
1. Seed Round 10-Apr-2004 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Proteomika Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Bizkaia Seed Capital Venture Capital Minority 000 0000 000000 0

Proteomika Executive Team (3)

Name Title Board
Seat
Contact
Info
Laureano Simón Ph.D Chief Executive Officer
Antonio Martínez Ph.D Chief Operating Officer
Simon Cruz Ph.D Chief Scientific Officer